Patents by Inventor Alain Claude-Marie Daugan

Alain Claude-Marie Daugan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic amides as kinase inhibitors
    Patent number: 11485710
    Abstract: Disclosed are compounds having the formula: wherein R1, R2, and R3 are as defined herein, and methods of making and using the same.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: November 1, 2022
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew Anderson, Deepak Bandyopadhyay, Alain Claude-Marie Daugan, Frederic G. Donche, Patrick M. Eidam, Nicolas Eric Faucher, Nicolas S. George, Philip Anthony Harris, Jae U. Jeong, Bryan W. King, Clark A. Sehon, Gemma Victoria White, David Duff Wisnoski
  • Heterocyclic Amides as Kinase Inhibitors
    Publication number: 20210253532
    Abstract: Disclosed are compounds having the formula: wherein R1, R2, and R3 are as defined herein, and methods of making and using the same.
    Type: Application
    Filed: January 22, 2021
    Publication date: August 19, 2021
    Inventors: Niall Andrew Anderson, Deepak Bandyopadhyay, Alain Claude-Marie Daugan, Frederic G. Donche, Patrick M. Eidam, Nicolas Eric Faucher, Nicolas S. George, Philip Anthony Harris, Jae U. Jeong, Bryan W. King, Clark A. Sehon, Gemma Victoria White, David Duff Wisnoski
  • Heterocyclic amides as kinase inhibitors
    Patent number: 10899716
    Abstract: Disclosed are compounds having the formula: wherein R1, R2, and R3 are as defined herein, and methods of making and using the same.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: January 26, 2021
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Niall Andrew Anderson, Deepak Bandyopadhyay, Alain Claude-Marie Daugan, Frederic G. Donche, Patrick M. Eidam, Nicolas Eric Faucher, Nicolas S. George, Philip Anthony Harris, Jae U. Jeong, Bryan W. King, Clark A. Sehon, Gemma Victoria White, David Duff Wisnoski
  • HETEROCYCLIC AMIDES AS KINASE INHIBITORS
    Publication number: 20200165205
    Abstract: Disclosed are compounds having the formula: wherein R1, R2, and R3 are as defined herein, and methods of making and using the same.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 28, 2020
    Inventors: Niall Andrew ANDERSON, Deepak BANDYOPADHYAY, Alain Claude-Marie DAUGAN, Frederic G. DONCHE, Patrick M. EIDAM, Nicolas Eric FAUCHER, Nicolas S. GEORGE, Philip Anthony HARRIS, Jae U. JEONG, Bryan W. KING, Clark A. SEHON, Gemma Victoria WHITE, David Duff WISNOSKI
  • Heterocyclic amides as kinase inhibitors
    Patent number: 10590085
    Abstract: Disclosed are compounds having the formula (I): wherein R1, R2, and R3 are as defined herein, and methods of making and using the same.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: March 17, 2020
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Niall Andrew Anderson, Deepak Bandyopadhyay, Alain Claude-Marie Daugan, Frederic G. Donche, Patrick M. Eidam, Nicolas Eric Faucher, Nicolas S. George, Philip Anthony Harris, Jae U. Jeong, Bryan W. King, Clark A. Sehon, Gemma Victoria White, David Duff Wisnoski
  • HETEROCYCLIC AMIDES AS KINASE INHIBITORS
    Publication number: 20190345138
    Abstract: Disclosed are compounds having the formula: wherein R1 and R2 are as defined herein, and methods of making and using the same.
    Type: Application
    Filed: November 17, 2017
    Publication date: November 14, 2019
    Inventors: Alain Claude-Marie DAUGAN, Frederic G. DONCHE, Nicolas Eric FAUCHER, Nicolas S. GEORGE
  • Chemical Compounds
    Publication number: 20180237441
    Abstract: The invention is directed to substituted pyrrolidinone and imidazolidinone derivatives. Specifically, the invention is directed to compounds according to Formula I: wherein R1, R2, R3, R4, R5, R6, R7, X and Y are as defined herein.
    Type: Application
    Filed: September 15, 2016
    Publication date: August 23, 2018
    Inventors: Jeffrey Michael AXTEN, Alain Claude-Marie DAUGAN, Nicolas Eric FAUCHER, Raghava Reddy KETHIRI, Rajendra KRISTAM, Chandregowda VENKATESHAPPA
  • HETEROCYCLIC AMIDES AS KINASE INHIBITORS
    Publication number: 20180134665
    Abstract: Disclosed are compounds having the formula (I): wherein R1, R2, and R3 are as defined herein, and methods of making and using the same.
    Type: Application
    Filed: May 19, 2016
    Publication date: May 17, 2018
    Inventors: Niall Andrew ANDERSON, Deepak BANDYOPADHYAY, Alain Claude-Marie DAUGAN, Frederic G. DONCHE, Patrick M. EIDAM, Nicolas Eric FAUCHER, Nicolas S. GEORGE, Philip Anthony HARRIS, Jae U. JEONG, Bryan W. KING, Clark A. SEHON, Gemma Victoria WHITE, David Duff WISNOSKI
  • Quinolinone derivatives
    Patent number: 9855260
    Abstract: The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: January 2, 2018
    Assignee: GLAXOSMITHKLINE LLC
    Inventors: Alain Claude-Marie Daugan, Yann Lamotte, Olivier Mirguet
  • QUINOLINONE DERIVATIVES
    Publication number: 20150238480
    Abstract: The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
    Type: Application
    Filed: May 11, 2015
    Publication date: August 27, 2015
    Inventors: Alain Claude-Marie DAUGAN, Yann LAMOTTE, Olivier MIRGUET
  • Quinolinone derivatives
    Patent number: 9061998
    Abstract: The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: June 23, 2015
    Assignee: GlaxoSmithKline LLC
    Inventors: Alain Claude-Marie Daugan, Olivier Mirguet, Yann Lamotte
  • 1H-PYROLLO[3,2-D]PYRIMIDINEDIONE DERIVATIVES
    Publication number: 20130345243
    Abstract: The present invention relates to pyrimidinedione compounds of formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds of formula (I) or salts thereof as activators of AMPK.
    Type: Application
    Filed: March 5, 2012
    Publication date: December 26, 2013
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: Anne Marie Jeanne Bouillot, Alain Claude-Marie Daugan, Yann Lamotte, Olivier Mirguet
  • QUINOLINONE DERIVATIVES
    Publication number: 20130345212
    Abstract: The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
    Type: Application
    Filed: March 5, 2012
    Publication date: December 26, 2013
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: Alain Claude-Marie Daugan, Olivier Mirguet, Yann Lamotte
  • Condensed Azepine Derivatives As Bromodomain Inhibitors
    Publication number: 20120202799
    Abstract: Benzodiazepine compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.
    Type: Application
    Filed: November 3, 2010
    Publication date: August 9, 2012
    Inventors: Miriam Crowe, Alain Claude-Marie Daugan, Romain Luc Marie Gosmini, Richard Martin Grimes, Olivier Mirguet, Jacqueline Elizabeth Mordaunt
  • THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE
    Publication number: 20100120669
    Abstract: The present invention relates to substituted thiadiazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: February 26, 2008
    Publication date: May 13, 2010
    Inventors: Anne Marie Jeanne Bouillot, Thierry Boyer, Alain Claude-Marie Daugan, Anthony William Dean, Martin Christian Fillmore, Yann Lamotte
  • COMPOUNDS
    Publication number: 20100048617
    Abstract: The present invention relates to substituted 3-Aminopyrazole compounds of formula (I) and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: December 19, 2007
    Publication date: February 25, 2010
    Inventor: Alain Claude-Marie Daugan
  • Compounds
    Publication number: 20100041696
    Abstract: The present invention relates to substituted 4-Aminopyrazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: December 19, 2007
    Publication date: February 18, 2010
    Inventors: Alain Claude-Marie Daugan, Anthony William Dean
  • COMPOUNDS
    Publication number: 20100022486
    Abstract: The present invention relates to substituted 3-Aminopyrazole compounds of formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: December 19, 2007
    Publication date: January 28, 2010
    Inventors: Anne Marie Jeanne Bouillot, Alain Claude-Marie Daugan, Anthony William Dean, Martin Christian Fillmore
  • Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
    Patent number: 6962918
    Abstract: Compounds of the general structural formula (I), and use of the compounds and salts and solvates thereof, as therapeutic agents.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: November 8, 2005
    Assignee: Lilly Icos LLC.
    Inventors: Mark W. Orme, Lisa M. Schultze, Jason Scott Sawyer, Alain Claude-Marie Daugan, Raymond Brown
  • Pyrazino[1?,2?:1,6]pyrido[3,4b]indole derivatives
    Patent number: 6911542
    Abstract: Compounds of the general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: June 28, 2005
    Assignee: Lilly Icos LLC.
    Inventors: Mark W. Orme, Jason Scott Sawyer, Lisa M. Schultze, Alain Claude-Marie Daugan, Francoise Gellibert